|
19 Jan 2010 |
Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite and Cat Allergies
|
|
19 Jan 2010 |
Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
|
|
15 Jan 2010 |
International Medica Foundation Reaches Final Vaccination Milestone in Phase II Clinical Trial for Rotavirus Vaccine
|
|
13 Jan 2010 |
Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU AVIR Green Hills Biotechnology AG
|
|
13 Jan 2010 |
Xcellerex Initiates Phase I Clinical Trial of Novel Yellow Fever Vaccine
|
|
12 Jan 2010 |
NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
|
|
11 Jan 2010 |
Inhibitex Provides Update on Its Staph Vaccine, FV-100 and INX-189 Development Programs
|
|
07 Jan 2010 |
Mechanism of Action for Vical's Vaxfectin(R) Adjuvant Expands Potential Applications
|
|
07 Jan 2010 |
Hawaii Biotech Completes Dosing of Phase 1 Trial for Dengue Virus Monovalent Vaccine
|
|
04 Jan 2010 |
Intercell starts an additional efficacy trial for its patch-based investigational Travelers’ Diarrhea Vaccine System in Asia
|
|
30 Dec 2009 |
Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
|
|
29 Dec 2009 |
Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing
|
|
29 Dec 2009 |
Vical Confirms Advantages of DNA Technology Platform With Vaccine for H1N1 Influenza
|
|
28 Dec 2009 |
Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
|
|
28 Dec 2009 |
Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
|
|
28 Dec 2009 |
Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanese Encephalitis
|
|
21 Dec 2009 |
All three Novartis A(H1N1) 2009 influenza vaccines prequalified by World Health Organization (WHO) for use in developing world
|
|
21 Dec 2009 |
Medicago reports positive Phase I results for its avian flu pandemic vaccine
|
|
18 Dec 2009 |
Novartis meningococcal vaccine Menveo® recommended for approval in the European Union for prevention of disease in adolescents and adults
|
|
16 Dec 2009 |
Intercell provides update on ongoing Phase II vaccine studies
|
|
16 Dec 2009 |
Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
|
|
15 Dec 2009 |
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
|
|
14 Dec 2009 |
Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children
|
|
14 Dec 2009 |
Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
|
|
11 Dec 2009 |
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
|
